{
    "eid": "2-s2.0-84938149769",
    "title": "MIB-1 index as a surrogate for mitosis-karyorrhexis index in neuroblastoma",
    "cover-date": "2015-07-27",
    "subject-areas": [
        {
            "$": "Pathology and Forensic Medicine",
            "@code": "2734"
        },
        {
            "$": "Surgery",
            "@code": "2746"
        },
        {
            "$": "Anatomy",
            "@code": "2702"
        }
    ],
    "keywords": [
        "image analysis",
        "Ki-67",
        "MIB-1",
        "MKI",
        "neuroblastoma"
    ],
    "authors": [
        "Taywin Atikankul"
    ],
    "citedby-count": 13,
    "ref-count": 23,
    "ref-list": [
        "Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group",
        "Neuroblastoma",
        "Recent advances in neuroblastoma",
        "A Systematic Review of Molecular and Biological Tumor Markers in Neuroblastoma",
        "The International Neuroblastoma Risk Group (INRG) classification system: An INRG task force report",
        "Peripheral neuroblastic tumors: Pathologic classification based on recommendations of International Neuroblastoma Pathology Committee (Modification of Shimada Classification)",
        "Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas",
        "The International Neuroblastoma Pathology Classification (the Shimada system)",
        "International Neuroblastoma Pathology Classification for prognostic evaluation of patients with peripheral neuroblastic tumors: A report from the Children's Cancer Group",
        "Age-dependent prognostic effect by mitosis-karyorrhexis index in neuroblastoma: A report from the children's oncology group",
        "Ki67 protein: The immaculate deception?",
        "The Ki-67 protein: From the known and the unknown",
        "Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: A study of 182 cases from the Spanish Neuroblastoma Registry",
        "Immunoexpression of cell cycle biomarkers in neuroblastoma samples and its correlation with prognostic factors",
        "Proliferation and apoptosis in neuroblastoma: subdividing the mitosis-karyorrhexis index",
        "Evaluation of Ki-67 Reactivity in Neuroblastoma Using Paraffin Embedded Tissue",
        "Proliferation marker Ki-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification",
        "Prognostic significance of the proliferative activity in neuroblastoma",
        "Chromogenic in situ hybridization-detected hotspot MYCN amplification associates with Ki-67 expression and inversely with nestin expression in neuroblastomas",
        "Comparative analysis of methods for accurate recognition of cells through nuclei staining of Ki-67 in neuroblastoma and estrogen/progesterone status staining in breast cancer",
        "Study of proliferation and apoptosis in neuroblastoma. Their relation with other prognostic factors",
        "Expression of Ki-67, p53 and VEGF in pediatric neuroblastoma",
        "Computer-aided prognosis of neuroblastoma: Detection of mitosis and karyorrhexis cells in digitized histological images"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Rajamangala University of Technology Phra Nakhon",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Toronto",
            "affilname": "The Hospital for Sick Children",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Toronto",
            "affilname": "University of Toronto Faculty of Medicine",
            "affiliation-country": "Canada"
        }
    ],
    "funding": []
}